Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. by Bonifacio, E, Lernmark, A, Dawkins, R

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (vol 48, pg 703, 2005) by Bottazzo, G, Bosi, E, Cull, C, Bonifacio, E, Locatelli, M, Zimmet, P, Mackay, I, Holman, R

Erratum: IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71) (Diabetologia (2005) 48 (703-708) DOI: htt... by Bottazzo, G, Bosi, E, Cull, C, Bonifacio, E, Locatelli, M, Zimmet, P, Mackay, I, Holman, R

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71). by Bottazzo, G, Bosi, E, Cull, C, Bonifacio, E, Locatelli, M, Zimmet, P, Mackay, I, Holman, R

Relationship of autoantibodies to glutamic acid decarboxylase (GADA) to deterioration of glycamic control assessed by therapy progression in latent autoimmune diabetes in adults (L... by Clark, A, Desai, M, Cull, C, Horton, V, Christie, MR, Bingley, P, Bonifacio, E, Levy, J, Holman, R

Aeromonas spp. IN PRODUCTS OF ANIMAL ORIGIN AND DRINKING WATER OF GOIÂNIA-GO Aeromonas spp. EM PRODUTOS DE ORIGEM ANIMAL E EM ÁGUA DE CONSUMO DE GOIÂNIA - GO by Albenones José de Mesquita, Iolanda Aparecida Nunes, Antônio Nonato de Oliveira, Moacir Evandro Lage, Edson Marden Bonifácio e Souza

Get full text

GAD65 autoantibody titres at diagnosis in Latent Autoimmune Diabetes in Adults (LADA) differ from Type 1 diabetes (T1D) and together with epitope specificity predict insulin requir... by Desai, M, Williams, A, Horton, V, Bingley, P, Levy, J, Cull, C, Holman, R, Bonifacio, E, Christie, MR, Clark, A

GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77. by Desai, M, Cull, C, Horton, V, Christie, MR, Bonifacio, E, Lampasona, V, Bingley, P, Levy, J, Mackay, I, Zimmet, P, Holman, R, Clark, A

Allele-specific methylation of type 1 diabetes susceptibility genes by Kindt, A, Fuerst, R, Knoop, J, Laimighofer, M, Telieps, T, Hippich, M, Woerheide, M, Wahl, S, Wilson, R, Sedlmeier, E, Hommel, A, Todd, J, Krumsiek, J, Ziegler, A, Bonifacio, E

Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity by Bonifacio, E, Mathieu, C, Nepom, G, Ziegler, A, Anhalt, H, Haller, M, Harrison, L, Hebrok, M, Kushner, J, Norris, J, Peakman, M, Powers, A, Todd, J, Atkinson, M

Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary... by Ziegler, A, Achenbach, P, Berner, R, Casteels, K, Danne, T, Gündert, M, Hasford, J, Hoffmann, V, Kordonouri, O, Lange, K, Elding Larsson, H, Lundgren, M, Snape, M, Szypowska, A, Todd, J, Bonifacio, E, Gppad Study Group

Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemic by Zeller, I, Weiss, A, Arnolds, S, Schütte-Borkovec, K, Arabi, S, von dem Berge, T, Casteels, K, Hommel, A, Kordonouri, O, Larsson, HE, Lundgren, M, Rochtus, A, Snape, MD, Szypowka, A, Vatish, M, Winkler, C, Bonifacio, E, Ziegler, A

Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes by Hummel, S, Rosenberger, S, von dem Berge, T, Besser, REJ, Casteels, K, Hommel, A, Kordonouri, O, Elding Larsson, H, Lundgren, M, Marcus, BA, Oltarzewski, M, Rochtus, A, Szypowska, A, Todd, JA, Weiss, A, Winkler, C, Bonifacio, E, Ziegler, A

Successful integration of newborn genetic testing into UK routine screening using prospective consent to determine eligibility for clinical trials by Bendor-Samuel, OM, Wishlade, T, Willis, L, Aley, P, Choi, E, Craik, R, Mujadidi, Y, Mounce, G, Roseman, F, De La Horra Gozalo, A, Bland, J, Taj, N, Smith, I, Ziegler, A-G, Bonifacio, E, Winkler, C, Haupt, F, Todd, JA, Servais, L, Snape, MD, Vatish, M

Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD‐02 study design and first results by Winkler, C, Haupt, F, Heigermoser, M, Zapardiel-Gonzalo, J, Ohli, J, Faure, T, Kalideri, E, Hommel, A, Delivani, P, Berner, R, Kordonouri, O, Roloff, F, Von Dem Berge, T, Lange, K, Oltarzewski, M, Glab, R, Szypowska, A, Snape, M, Vatish, M, Todd, J, Larsson, H, Ramelius, A, Kördel, J, Casteels, K, Paulus, J, Ziegler, A, Bonifacio, E, GPPAD Study Group